Total Holdings
66
Portfolio diversification across 66 positions
HELX
(BATS)Franklin Genomic Advancements ETF
$39.36-- (--)
Loading... - Market loading
HELX ETF Holdings: Franklin Genomic Advancements ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$23.05M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Franklin Templeton
BATS
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Guardant Health, Inc | Stock | 8.89% |
| 2 |  | Natera, Inc. | Stock | 6.78% |
| 3 |  | Krystal Biotech, Inc. | Stock | 6.17% |
| 4 |  | Ligand Pharmaceuticals Incorporated | Stock | 4.18% |
| 5 |  | United Therapeutics Corporation | Stock | 3.98% |
| 6 |  | Adaptive Biotechnologies Corporation | Stock | 3.90% |
| 7 |  | BridgeBio Pharma, Inc | Stock | 3.56% |
| 8 |  | Eli Lilly and Company | Stock | 3.21% |
| 9 | L LSE:AZN | AstraZeneca PLC | Stock | 2.91% |
| 10 | L LON:AZN | AstraZeneca PLC | Stock | 2.85% |
| 11 |  | Vertex Pharmaceuticals Incorporated | Stock | 2.81% |
| 12 |  | Travere Therapeutics, Inc. | Stock | 2.73% |
| 13 |  | Twist Bioscience Corporation | Stock | 2.63% |
| 14 | K KRX:207940 | Samsung Biologics Co.,Ltd. | Stock | 2.48% |
| 15 |  | Insmed Incorporated | Stock | 2.48% |
| 16 | K KO:207940 | Samsung Biologics Co Ltd | Stock | 2.37% |
| 17 |  | Corteva, Inc. | Stock | 2.29% |
| 18 |  | Medpace Holdings, Inc | Stock | 2.16% |
| 19 |  | Alnylam Pharmaceuticals, Inc | Stock | 2.11% |
| 20 |  | Neurocrine Biosciences, Inc | Stock | 2.00% |
| 21 |  | Ionis Pharmaceuticals, Inc | Stock | 2.00% |
| 22 |  | Regeneron Pharmaceuticals, Inc. | Stock | 1.99% |
| 23 |  | Tempus AI, Inc. | Stock | 1.90% |
| 24 | E EBR:ARGX | Argen-X | Stock | 1.77% |
| 25 |  | Veracyte, Inc. | Stock | 1.60% |
| 26 |  | PTC Therapeutics, Inc | Stock | 1.50% |
| 27 |  | BioNTech SE | Stock | 1.49% |
| 28 |  | Stoke Therapeutics, Inc | Stock | 1.34% |
| 29 |  | Charles River Laboratories International, Inc | Stock | 1.17% |
| 30 |  | Cadence Design Systems, Inc | Stock | 1.12% |
| 31 |  | GRAIL, LLC | Stock | 1.08% |
| 32 |  | Repligen Corporation | Stock | 1.07% |
| 33 |  | CRISPR Therapeutics AG | Stock | 1.01% |
| 34 | E ETR:SRT3 | Sartorius Aktiengesellschaft | Stock | 0.96% |
| 35 |  | Axsome Therapeutics, Inc | Stock | 0.95% |
| 36 |  | AnaptysBio, Inc | Stock | 0.93% |
| 37 |  | Beam Therapeutics Inc | Stock | 0.89% |
| 38 |  | Catalyst Pharmaceuticals Inc | Stock | 0.86% |
| 39 |  | Jazz Pharmaceuticals plc | Stock | 0.86% |
| 40 |  | Thermo Fisher Scientific Inc | Stock | 0.80% |
| 41 |  | IQVIA Holdings Inc | Stock | 0.79% |
| 42 |  | CareDx, Inc | Stock | 0.76% |
| 43 |  | Praxis Precision Medicines, Inc | Stock | 0.71% |
| 44 |  | Agilent Technologies, Inc | Stock | 0.64% |
| 45 |  | Danaher Corporation | Stock | 0.61% |
| 46 |  | Hinge Health, Inc. | Stock | 0.61% |
| 47 | E ETR:QIA | QIAGEN N.V | Stock | 0.51% |
| 48 |  | Ultragenyx Pharmaceutical Inc | Stock | 0.49% |
| 49 |  | Arcutis Biotherapeutics, Inc | Stock | 0.44% |
| 50 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.37% |
Frequently Asked Questions About Franklin Genomic Advancements ETF Holdings
What are the top holdings in HELX?
Franklin Genomic Advancements ETF (HELX) holds 66 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is HELX's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review HELX's holdings table to analyze concentration risk.
What is HELX's sector allocation?
The Sector Allocation chart shows how HELX distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does HELX invest in?
HELX's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is HELX ETF?
HELX's diversification can be assessed by reviewing its 66 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.